Search research articles
Contact Us
Filters
Showing results (191-200 of 348) with videos related to
Page
of 35
Sort By:
Epileptic Disorders : International Epilepsy Journal with Videotape
|
August 4, 2015
Multiphasic presentation of Rasmussen's encephalitis
Andreja Avberšek, Anna Miserocchi, Andrew W McEvoy, et al.
Neuro-Oncology
|
December 6, 2013
Challenges for the functional diffusion map in pediatric brain tumors
Matthew Grech-Sollars, Dawn E Saunders, Kim P Phipps, et al.
Pediatric Rheumatology Online Journal
|
November 2, 2017
Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature
E L Binns, E Moraitis, S Maillard, et al.
Neuropathology and Applied Neurobiology
|
March 4, 2020
CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma
J R Apps, C Stache, J M Gonzalez-Meljem, et al.
Nature Ecology & Evolution
|
August 17, 2017
High taxonomic variability despite stable functional structure across microbial communities
Stilianos Louca, Saulo M S Jacques, Aliny P F Pires, et al.
BJU International
|
February 7, 2004
Endothelial nitric oxide synthase expression in neurogenic urinary bladders treated with intravesical resiniferatoxin
A N Apostolidis, Y Yiangou, C M Brady, et al.
Elife
|
March 27, 2019
Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS/YAP/TAZ cascade
Emily J Lodge, Alice Santambrogio, John P Russell, et al.
Journal of Immunological Methods
|
March 21, 1991
Generation of stimulated, lymphokine activated T killer (T-LAK) cells from the peripheral blood of normal donors and adult patients with recurrent glioblastoma
R S Yamamoto, J Coss, B Vayuvegula, et al.
Journal of Neuro-Oncology
|
February 1, 1993
Therapy of recurrent high grade gliomas with surgery, and autologous mitogen activated IL-2 stimulated killer (MAK) lymphocytes: I. Enhancement of MAK lytic activity and cytokine production by PHA and clinical use of PHA
E W Jeffes, Y B Beamer, S Jacques, et al.
Journal of Biological Response Modifiers
|
October 1, 1987
Preliminary clinical trial of immunotherapy for malignant glioma
M Ingram, C H Shelden, S Jacques, et al.
Page
of 35
Search research articles
Search
Showing results (191-200 of 348) with videos related to
Sort By:
Page
of 35
Epileptic Disorders : International Epilepsy Journal with Videotape
|
August 4, 2015
Multiphasic presentation of Rasmussen's encephalitis
Andreja Avberšek, Anna Miserocchi, Andrew W McEvoy, et al.
Neuro-Oncology
|
December 6, 2013
Challenges for the functional diffusion map in pediatric brain tumors
Matthew Grech-Sollars, Dawn E Saunders, Kim P Phipps, et al.
Pediatric Rheumatology Online Journal
|
November 2, 2017
Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature
E L Binns, E Moraitis, S Maillard, et al.
Neuropathology and Applied Neurobiology
|
March 4, 2020
CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma
J R Apps, C Stache, J M Gonzalez-Meljem, et al.
Nature Ecology & Evolution
|
August 17, 2017
High taxonomic variability despite stable functional structure across microbial communities
Stilianos Louca, Saulo M S Jacques, Aliny P F Pires, et al.
BJU International
|
February 7, 2004
Endothelial nitric oxide synthase expression in neurogenic urinary bladders treated with intravesical resiniferatoxin
A N Apostolidis, Y Yiangou, C M Brady, et al.
Elife
|
March 27, 2019
Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS/YAP/TAZ cascade
Emily J Lodge, Alice Santambrogio, John P Russell, et al.
Journal of Immunological Methods
|
March 21, 1991
Generation of stimulated, lymphokine activated T killer (T-LAK) cells from the peripheral blood of normal donors and adult patients with recurrent glioblastoma
R S Yamamoto, J Coss, B Vayuvegula, et al.
Journal of Neuro-Oncology
|
February 1, 1993
Therapy of recurrent high grade gliomas with surgery, and autologous mitogen activated IL-2 stimulated killer (MAK) lymphocytes: I. Enhancement of MAK lytic activity and cytokine production by PHA and clinical use of PHA
E W Jeffes, Y B Beamer, S Jacques, et al.
Journal of Biological Response Modifiers
|
October 1, 1987
Preliminary clinical trial of immunotherapy for malignant glioma
M Ingram, C H Shelden, S Jacques, et al.
Page
of 35